Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Data on the value of dietary supplements in reducing the risk of developing prostate cancer have been conflicting; however, two large randomized trials have indicated that prostate cancer risk is not reduced by the long-term use of vitamin E, vitamin C or selenium supplements.
Increasing the number of prostate biopsy cores taken does not improve diagnostic accuracy. Instead, urologists need to think in three dimensions and use template guidance to improve cancer detection and characterization.
The growth of prostate acini from single cell implants in mice is a major breakthrough. Such results have important clinical implications, and will ultimately change the treatment paradigm for prostatic disease.
